Predict prostate cancer score

Andreny Karoly nr. Histopathological diagnosis of PCa can be established by transrectal ultrasound-guided TRUS biopsy after an abnormal finding in digital rectal examination or finding an increased value of prostate specific antigen PSA in the blood.

The purpose of this study is to evaluate the correlation between PSA level and Gleason score, in order to predict prostate cancer aggressiveness at time of diagnosis. Keywords: prostate, cancer, PSA, Gleason, score.

Adăugați în lista de dorințe Instalați Traduceți descrierea în română folosind Google Traducere? Traduceți descrierea înapoi în engleză Statele Unite ale Americii Traduceți "Urology Partin Tables: Prostate Cancer Evaluation" is an app to help medical doctor or urologist to predict pathological stage of prostate cancer patients based on commonly available preoperative data serum prostate-specific antigen PSA level, clinical stage, and biopsy Gleason score. For decades, urologists around the world have relied on the tables for counseling patients preoperatively and for surgical planning. Download now! The use of "Urology Partin Tables: Prostate Cancer Evaluation" app may shift toward identifying men with intermediate-risk to high-risk disease for whom the ratio of treatment benefit to harm may be greatest, or to identify men with low-risk to intermediate-risk disease who may benefit from active surveillance.

References: 1. Cancer statistics, CA Cancer J Clin.

Recent trends in incidence of five common cancers in 26 European countries since analysis of the European Cancer Observatory. Eur J Cancer. EAU guidelines on prostate cancer.

Eur Urol. Pepe P, Pennisi M, Gleason score stratification according to age at diagnosis, Cancer statistics, Ioiart I. Prostata, Vol. I, nr. Alan Wein A, et al.